Disparities in exercise referral practices and barriers among oncologists in public and private institutions in Latin America.

P Paulo Gustavo Bergerot (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Cristiane Decat Bergerot (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) P Pamela Muniz (Oncoclínicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) M Maria Natalia Gandur-Quiroga (Department of Medical Oncology, Genitourinary Tumors, Institute of Oncology Angel H Roffo, Buenos Aires, Argentina) R Regina Barragan-Carrillo (Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico) L Lucia Viola (Fundacion Neumologica Colombia - Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center, Bogotá, Colombia) E Errol James Philip (University of California Los Angeles, Los Angeles, CA) J Jasmin Hundal (1Cleveland Clinic, Cleveland, United States) L Livia Mega (Oncoclínicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) D Dr. Paulo Sergio Lages (Oncoclínicas&Co, Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) R Renata Ferrari (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) A Angela S. Morabito (Dana-Farber Cancer Institute, Boston, MA) C Carolina Bernabe (Montefiore Einstein Comprehensive Cancer Center, Bronx, NY) M Mariana Laloni (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Carlos Gil Ferreira (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) M Murilo Buso (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) G Gilberto Lopes E Enrique Soto Pérez de Celis (National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico) N Narjust Florez (Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA) K Kathryn H. Schmitz

Abstract

1629 Background: Exercise offers significant benefit for patients with cancer, improving physical function, quality of life, and treatment-related outcomes. However, barriers such as limited referral practices and insufficient knowledge hinder its integration into care. This study compared referral practices, exercise assessment, and physicians’ perceptions in public (PUB) and private institutions (PRI). Methods: A cross-sectional survey of 454 physicians from 21 Latin American countries was conducted using a 25-item questionnaire on referral practices, patients’ exercise habits, and perceived barriers and facilitators to implementing exercise programs. Descriptive statistics summarized respondent characteristics and adherence to exercise-related practices. Chi-square tests were used to compare differences in referral practices and perceived barriers/facilitators between physicians working in PUB versus PRI institutions. Results: Out of 454 participants, most were from PUB (52%), mainly from Mexico (17%), Brazil (12%), and Colombia (10%). In the PRI (48%), Brazil led with 51%, followed by Argentina (18%), and Peru (8%). Female representation was higher in PUB compared to PRI (57% vs. 43%, P = 0.01). Physicians in PUB were less likely than those in PRI to assess exercise habits (53% vs. 18%, P = 0.001), refer patients (72% vs. 36%, P = 0.001), or provide guidance (56% vs. 12%, P = 0.001). Resource limitations were more common in PUB (e.g., no referral location: 86% vs. 70%, P = 0.04). Barriers included treatment side effects (PUB: 66% vs. PRI: 40%, P = 0.001) and lack of knowledge on prescribing exercise (PUB: 63% vs. PRI: 27%, P = 0.001). Physicians in PUB emphasized facilitators like access to qualified professionals (90% vs. 66%, P = 0.001) and personal experience (90% vs. 80%, P = 0.01). Conclusions: This study reveals significant disparities in cancer exercise practices between oncologists in public and private institutions across Latin America. Oncologists in public institutions were less likely to assess exercise, refer patients to exercise programs, and provide guidance. They also reported greater barriers, such as treatment side effects and lack of knowledge on exercise prescription and resources. Facilitators such as access to qualified professionals were less prominent in public institutions. These findings highlight the need for targeted interventions to improve exercise integration in cancer care, particularly in resource-limited settings.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
Pages 1629-1629
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

P

Paulo Gustavo Bergerot

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Cristiane Decat Bergerot

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

P

Pamela Muniz

Oncoclínicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

M

Maria Natalia Gandur-Quiroga

Department of Medical Oncology, Genitourinary Tumors, Institute of Oncology Angel H Roffo, Buenos Aires, Argentina

R

Regina Barragan-Carrillo

Instituto Nacional de Ciencias Medicas y Nutrición Salvador Zubirán, Mexico City, Mexico

L

Lucia Viola

Fundacion Neumologica Colombia - Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center, Bogotá, Colombia

E

Errol James Philip

University of California Los Angeles, Los Angeles, CA

J

Jasmin Hundal

1Cleveland Clinic, Cleveland, United States

L

Livia Mega

Oncoclínicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

D

Dr. Paulo Sergio Lages

Oncoclínicas&Co, Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

R

Renata Ferrari

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

A

Angela S. Morabito

Dana-Farber Cancer Institute, Boston, MA

C

Carolina Bernabe

Montefiore Einstein Comprehensive Cancer Center, Bronx, NY

M

Mariana Laloni

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Carlos Gil Ferreira

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

M

Murilo Buso

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

G

Gilberto Lopes

E

Enrique Soto Pérez de Celis

National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico

N

Narjust Florez

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

K

Kathryn H. Schmitz